Many other conditions can mimic the symptoms of prostate cancer, both in its early or advanced stages. Here's what you need ...

Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.

Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), accord ...

As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical ...

"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...

The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

The WOLVERINE meta-analysis reinforces the role of MDT in delaying disease progression in patients with oligometastatic ...

Continuing PSA screening in older men is common practice but not recommended, highlighting the need for clearer guidance.

The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...

Elevated circulating tumor DNA fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases. Elevated circulating tumor DNA (ctDNA ...